Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

REYKJAVIK, ICELAND (August 19, 2026) - Alvotech (NASDAQ: ALVO; ALVO-SDB) ("Alvotech" or the "Company"), a global biotechnology company specializing in the development and manufacture of biosimilar...